Navigation Links
STAAR Surgical's Visian ICL Procedure Performed Live on NBC's Today show
Date:3/4/2008

MONROVIA, Calif., March 4 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, congratulates Dr. Brian Boxer Wachler on his live surgical procedure on NBC's Today Show this morning correcting NBCSports.com columnist Alan Abrahamson's vision with STAAR's Visian ICL lenses.

The Visian ICL is the only foldable, minimally invasive lens approved in the U.S. for the correction of myopia, or nearsightedness, in adults. It can be especially useful in patients such as Abrahamson, who had a high prescription requirement to correct his nearsighted vision. The Visian ICL is approved for myopic patients as low as -3.0 diopters and delivers exceptional clarity and quality of vision.

During the brief procedure, which commonly takes 15 to 20 minutes per eye, Dr. Boxer Wachler made a micro incision to allow positioning of the implant behind the iris and in front of the natural lens. Both eyes were corrected during the show and Abrahamson was asked about any pain during the procedure by Meredith Vieira, co-anchor of the Today Show, to which he responded, "I cannot feel a thing." Before the procedure Abrahamson was unable to see the largest letter on the standard vision chart. Post-operatively, he said he could see "crisply and cleanly." He showed significant improvement instantaneously.

The Today Show segments can be viewed at:

http://www.msnbc.msn.com/id/21134540/vp/23463382#23463382

The implantable Collamer lens has been successfully implanted in over 80,000 eyes worldwide. In an FDA clinical trial, over 99 percent of patients were sat
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. STAAR Surgical Reports Operational Progress
2. STAAR Surgical Announces Third Quarter 2007 Earnings Release Date and Conference Call
3. STAAR Surgical to Purchase Canons Interest in Japanese Joint Venture
4. STAAR Surgical Reports Third Quarter Results
5. Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical
6. STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference
7. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
8. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
9. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
10. UK junior doctors gaining less experience of common procedures
11. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... This week, 60 Minutes ... laminate flooring products, initiating widespread concern from homeowners. ... materials made primarily from bamboo, stands behind their ... flooring products for volatile organic compounds (VOCs) through ... (BMH). Results from formaldehyde emissions testing show ...
(Date:3/5/2015)... 05, 2015 Testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ... heart attacks, strokes and other serious cardiovascular events due ... to move forward in the federal multidistrict litigation now ... According to a Case Management Order issued on March ... use of master pleadings in the proceeding. Among other ...
(Date:3/5/2015)... The Maricopa Community Colleges add $7.3 ... economy each year, according to a research report released ... Maricopa County Community College District, summarizes economic impact and ... year 2013-2014. , The analysis was conducted by ... that specializes in providing economic impact studies and labor ...
(Date:3/5/2015)... TCS Healthcare Technologies (TCS), a leading provider of ... arena, is pleased to announce a webinar focusing on ... (ACUITY) version 7.20. The session will focus on the ... automation. , The webinar, scheduled for March 18, 2015 ... Frater, RN, BSN, Director of Partner Development at TCS. ...
(Date:3/5/2015)... 2015 Califia Farms , the ... natural products coffee drinks category[1], today unveils its new ... in Anaheim, Calif. Concentrated Cold Brew (CCB) is ... which democratizes the next wave of the coffee-taste evolution ... to become their own baristas. , Califia Farms ...
Breaking Medicine News(10 mins):Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4
... Palmer Hospital, are hosting Grossology, an interactive exhibit designed to teach ... ... (PRWEB) January 29, 2009 -- The Orlando Science Center and presenting ... Science of the Human Body, a colorful, hands-on exhibit that uses ...
... funding research for the genetic disorder cystinosis, unveils new communication ... ... Forest, IL (PRWEB) January 29, 2009 -- The Cystinosis Research ... for the rare genetic disorder cystinosis, has launched a new ...
... CHARENTON-LE-PONT, France, January 29 , - A New ... 9.7% Excluding the Currency Effect, - Higher Earnings ... in ophthalmic optics, today,announced consolidated revenue of EUR3,074.5 million for the ... previous,year. Excluding the currency effect, growth for the year was a ...
... OH, January 29, 2009 -- Recent studies have suggested ... among children born very prematurely. The early symptoms ... to preterm births, such as cerebral palsy, which can ... Because of this, researchers have begun to explore ...
... "super bugs" because our antibiotic arsenal has run dry, leaving ... infectious disease researchers at The University of Texas Medical School ... The New England Journal of Medicine , Barbara E. Murray, ... and future response to preventing and treating "super bugs." , ...
... Dramatic New Study Presented in Congressional Briefing TodayOAKLAND, ... which Congress prepared to vote on the Obama ... nation,s largest organization of registered nurses said expanding ... of the most effective economic recovery programs - ...
Cached Medicine News:Health News:Grossology Exhibit Captivates Kids at The Orlando Science Center 2Health News:Grossology Exhibit Captivates Kids at The Orlando Science Center 3Health News:Cystinosis Research Network Unveils New Communication Strategy and Website 2Health News:Essilor : 2008 Revenue 2Health News:Essilor : 2008 Revenue 3Health News:Essilor : 2008 Revenue 4Health News:Essilor : 2008 Revenue 5Health News:Essilor : 2008 Revenue 6Health News:New study explores the relationship between preterm birth and autism spectrum disorder 2Health News:Call to action: Running out of options to fight ever-changing 'super bugs' 2Health News:Call to action: Running out of options to fight ever-changing 'super bugs' 3Health News:Nurses to Congress: Expanding Medicare Could Reverse Job Losses, and Repair Our Broken Healthcare System and Safety Net 2Health News:Nurses to Congress: Expanding Medicare Could Reverse Job Losses, and Repair Our Broken Healthcare System and Safety Net 3
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "Japan Pharma Outlook 2015: Year to Watch out ... report to their offering. The ... from April -2014 (Annexure 1) is a game ... whether generic or innovator. The most of the companies ...
(Date:3/5/2015)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... be held March 8-11, 2015, in Laguna ... , Chief Executive Officer, will provide an overview of ... be available to participate in one-on-one meetings with investors ...
(Date:3/5/2015)... -- According to a new market research ... Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User ... - Analysis & Global Forecast to 2019" , the ... $1,107.4 Million by 2019 from $887.8 Million in 2014, ... 4.5% during the forecast period. Browse ...
Breaking Medicine Technology:Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3ContraVir to Present at 27th Annual ROTH Conference 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
... 3, 2012 Cardium Therapeutics (NYSE Amex: ... with NYSE Amex LLC (formerly the American Stock Exchange). ... now in excess of the threshold requirements under Section ... (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) ...
... Calif., Jan. 3, 2012 BioMarin Pharmaceutical Inc. (Nasdaq: ... New Drug (IND) application for BMN-111, an analog of ... company expects to initiate the Phase 1 trial in ... demonstrated benefits in moderately and severely affected animal models ...
Cached Medicine Technology:Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines 2Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines 3Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines 4BioMarin Announces IND for BMN-111 for Achondroplasia is Active 2BioMarin Announces IND for BMN-111 for Achondroplasia is Active 3BioMarin Announces IND for BMN-111 for Achondroplasia is Active 4
Intended for the quantitative determination of total protein in serum. Reaction: endpoint. Wavelength: 540 nm. Linearity: 12 g/dL (120 g/L). Ready to use liquid reagent....
For the determination of urea nitrogen in human serum....
... Intended for the quantitative determination ... Reaction: kinetic, lag phase of ... by linear phase of at ... nm. Linearity: 120 mg/dL (42.8 ...
For the quantitative determination of direct bilirubin in human serum. Linearity: 20 mg/dl...
Medicine Products: